Department of Medicine
Department of Medicine
Central, Hong Kong1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, skin disorder, vesiculobullous skin disease | Active, not recruiting | Phase 2 | 2025-07-08 | NCT04400994 |